The report "Intracardiac Echocardiography (ICE) Market by Product (Ultrasound (2D, 3D/4D, Doppler), Catheter, Console, Software), Application (Valve Defects, Electrophysiology, Monitoring), Enduser (Hospital, ASC, Diagnostic Centers) & Region Global Forecasts to 2029", is projected to reach USD 545 million by 2029 from USD 333 million in 2024, growing at a CAGR of 10.3% during the forecast period. The market for intracardiac echocardiography (ICE) is expanding due to a number of complementary factors, such as the increased prevalence of cardiovascular conditions, ongoing advancements in ICE technology, an ageing population, and fostering public-private support for research.

Browse 280 market data Tables and 59 Figures spread through 313 Pages and in-depth TOC on "Intracardiac Echocardiography (ICE) Market by Product (Ultrasound (2D, 3D/4D, Doppler), Catheter, Console, Software), Application (Valve Defects, Electrophysiology, Monitoring), Enduser (Hospital, ASC, Diagnostic Centers) & Region Global Forecasts to 2029"

Download PDF - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=95683005

ICE Catheters segment to register a significant growth rate over the forecast period of 2024-2029.

Based on the product, the intracardiac echocardiography (ICE) market is segmented into ICE Ultrasound Systems with Inbuild Software Applications (2D ultrasound systems, 3D/4D ultrasound systems, doppler ultrasound systems), ICE Catheters (Doppler ICE catheters, phased - array ICE catheters, fixed - array ICE catheters, mechanical rotational ICE catheters) , ICE Consoles (cart/ trolley-based consoles, hand-held/ portable consoles), guiding catheters and sheaths, disposable accessories, and softwares. It is mostly driven by increased global prevalence of cardiac issues, better picture quality, faster treatment times, and real-time guidance during interventions. High-resolution images are essential for accurate device placement in transcatheter procedures. These elements work together to propel intracardiac echocardiography console acceptance and market expansion in the healthcare sector.

Electrophysiology segment to account for a significant market share in the intracardiac echocardiography (ICE) market in 2023.

Based on application, The intracardiac echocardiography (ICE) market is categorized into structural heart defects (mitral valve repair/ replacement, aortic valve replacement and other heart defects), electrophysiology, left atrial appendage closure, cardiac monitoring, and other applications, with electrophysiology dominating the market share in 2023. This prevalence of electrophysiology is driven by elements like  the growing burden of cardiac disorders and the ongoing advancements in ICE technology allow for continuous, real-time visualisation of cardiac structures, which is essential for monitoring procedural complications and ensuring patient safety during interventions. These elements work together to improve the safety and effectiveness of different cardiac operations, which is why intracardiac echocardiography is being used frequently for electrophysiology applications.

North America to account for a significant market share in the intracardiac echocardiography (ICE) market in 2023.

Based on region, The intracardiac echocardiography (ICE) market is categorized into North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa, with North America dominating the market share in 2023. This North American dominance is fueled by elements like  an a high incidence of cardiac diseases in North America, minimally invasive cardiac operations becoming a growing trend. Additionally, real-time monitoring and enhanced imaging capabilities help to maximise the efficacy of cardiac procedures. The adoption of innovative technologies, including ICE, is facilitated by North America's sophisticated healthcare infrastructure and the existence of prominent medical device businesses, promoting market growth.

As of 2023, prominent players in the intracardiac echocardiography (ICE) market are GE Healthcare (US), Medtronic (Ireland), Johnson & Johnson Medtech (US), Siemens Healthineers (Germany),  Abbott Laboratories (US) and Boston Scientific Corporation (US), among others.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.